Experts from Penn Medicine’s Endocrine Disease team including endocrinology, radiology, and pathology discuss the implementation and application of the evidence-based Thyroid Nodule Management Pathway. Drs. Susan Mandel, MD, MPH, Zubair Baloch, MD, PhD, Jeremy Flood, MD, and Jill Langer, MD help guide and address critical decision making points along this patient-centered pathway. They elaborate on evidence based evaluation for patients with thyroid nodules, the association of sonographic imaging with cancer risk and its application to FNA decision making, and the Bethesda cytology classification for reporting thyroid nodule FNA results and the indications for molecular testing, among other topics.
Related Links:
Thyroid Cancer, Nodule Management and COVID-19 | Penn Medicine
Twitter @PennMDForum
Dr. Baloch’s physician profile
Dr. Flood’s physician profile
Dr. Langer’s physician profile
Published
October 15, 2020
Created by
